Navigation Links
Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial

re permitted to roll over to pegylated interferon plus ribavirin for up to 48 weeks of total treatment; all eligible patients elected to do so.

"These results support our hypothesis that valopicitabine can be administered in combination with pegylated interferon and ribavirin," said Douglas Mayers, M.D., executive vice president and chief medical officer of Idenix Pharmaceuticals. "We are very pleased with the viral kinetics and HCV RNA clearance rates observed in patients treated with triple combination therapy in this study and look forward to further development of this combination."

About Valopicitabine

Valopicitabine is an investigational nucleoside polymerase inhibitor being evaluated in ongoing clinical trials for the treatment of hepatitis C. The most common adverse events reported in valopicitabine clinical trials to date include nausea, vomiting, fatigue, diarrhea, headache, flu-like symptoms and depression. Idenix is developing valopicitabine in collaboration with Novartis Pharma AG.

About Hepatitis C

HCV infection is the most common chronic blood-borne infection in the United States.(1) The Centers for Disease Control and Prevention estimates that 4 million Americans have been infected with HCV, and 2.7 million of these carry chronic HCV infections.(2) Hepatitis C-related liver failure is the most common indication for liver transplantation in the United States.(2) As the prevalence of severe liver disease attributable to hepatitis C rises, deaths due to complications from hepatitis C infection, currently 8,000 to 10,000 per year in the United States, are increasing and are expected to triple by 2010.(3)

Conference Call Information

Idenix will hold a conference call today at 8:30 a.m. EDT. To access the call please dial (800) 774-5358 U.S./Canada or (706) 758-9475 International and enter passcode 3143678 or to listen to a live webcast of the call, go to "Calendar of Events" in the Idenix Investor Center at
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Idenix Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C Genotype-1 Patients at the 42nd Annual Meeting of the European Association for the Study of the Liver
2. New Data Show Pfizers Axitinib Prolonged Overall Survival in Advanced Pancreatic Cancer When Combined with Standard of Care Chemotherapy
3. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
4. Low-Dose Steroid Combined With Lenalidomide Prolongs Survival Compared With High-Dose Steroid for Multiple Myeloma Treatment
5. RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments
6. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
7. Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care
8. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
9. Clinical Trial Results Change Standard of Care for Pancreatic Cancer Patients, Future Therapies Discussed
10. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
11. Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO
Post Your Comments:
(Date:8/27/2014)... Aug. 27, 2014 ISPE , the ... has released a preview of its Drug Shortages ... avoid drug shortages and maintain a robust and reliable ... The Plan, a first for the industry, was developed ... members and describes how industry can best prevent drug ...
(Date:8/27/2014)... Aug. 27, 2014 Pulse Systems, Inc. , ... Practice Management , and Revenue Cycle Management (RCM) ... practices performed by some RCM vendors, at UBM Medica,s ... on September 19-20, 2014.  A presenter ... in September with a new session encouraging practices to "Look ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com ... available in its catalogue: Global Animal ... About Animal Health Animal health ... diseases or treat animals to enhance their quality ... yield of animal food. The Global Animal Health ...
Breaking Medicine Technology:ISPE Releases First Look at its Plan to Prevent Drug Shortages 2ISPE Releases First Look at its Plan to Prevent Drug Shortages 3ISPE Releases First Look at its Plan to Prevent Drug Shortages 4Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 2Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 3Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 4Global Animal Health Market 2014-2018 2Global Animal Health Market 2014-2018 3Global Animal Health Market 2014-2018 4Global Animal Health Market 2014-2018 5Global Animal Health Market 2014-2018 6Global Animal Health Market 2014-2018 7
... Calif., March 15, 2012  With the economic crisis and ... unprecedented challenges. To flourish, clinics now will need to ... To facilitate this change in strategy, the California HealthCare ... announces the California Catalyst Fund , designed to ...
... March 15, 2012  Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical ... stem cells (CSCs) and tumor bulk, today announced that ... Since serving as Chief Executive Officer of Cephalon, ... Industries (Nasdaq: TEVA ) in October 2011, ...
Cached Medicine Technology:New Restructuring Fund Launches for California Community Clinics 2Stemline Therapeutics Appoints Kevin Buchi, Former CEO of Cephalon, to Its Board of Directors 2
(Date:8/27/2014)... Recently, UWDress.com, a popular supplier of wedding dresses ... new range of elegant bridesmaid dresses . There ... All the company's new and old customers can get ... , This experienced company focuses on affordable clothes ... bridal gowns, backless party outfits, princess wedding gowns and ...
(Date:8/27/2014)... Diego, CA (PRWEB) August 27, 2014 ... insurance policies will now be easier for the public ... insurance prices that are promoted in all 50 states ... . , The different insurers that are generating ... made it possible for adults to use the programmed ...
(Date:8/27/2014)... The New York Mobility Club (sponsored by ... about “ Sexuality & Intimacy ” for people with ... entertaining discussions are for mature audiences only. September 9 ... Mamaroneck, NY) and October 7 from 6-8 pm at ... The New York Mobility Club is a local community ...
(Date:8/27/2014)... Skirt Sports , the innovative women’s running apparel brand is ... most noted for her brave running of the 1967 all-male ... running clothes that unites the history of women’s competitive running ... , “It is such an honor to work with ... the original Skirt – she stood strong, pushing herself to ...
(Date:8/27/2014)... 2014 Seventy-three members of the founding ... the beginning of their careers as healthcare professionals at ... Students entering a four-year PharmD program traditionally receive white ... them into the profession as colleagues dedicated to patient ... the Garrison Theater in Claremont, Calif., KGI President Sheldon ...
Breaking Medicine News(10 mins):Health News:Elegant Bridesmaid Dresses For 2014 Now Available At UWDress.com 2Health News:Home Insurance Prices for All 50 States Now Supplied at Consumer Insurance Portal Online 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2Health News:Skirt Sports Launches Clothing Line with Legendary Runner Kathrine Switzer 2Health News:Founding Class of the KGI School of Pharmacy Formally Welcomed into the Profession at a Traditional White Coat Ceremony 2
... -- The U.S. Food and Drug Administration says it has ... commonly known as Avastin, is being sold in the United ... which the FDA says contains no active ingredient -- is ... medication that is approved for use in Turkey but not ...
... 4 (HealthDay News) -- There appears to be a ... best known as Depo-Provera, and an increased risk of ... For the study, researchers compared more than 1,000 Seattle-area ... breast cancer, and more than 900 women without breast ...
... YORK, APRIL 4, 2012 A new study offers ... lethal damage to the gastrointestinal (GI) tract caused by ... those occurring during a nuclear incident. There are currently ... condition, known as radiation gastrointestinal syndrome (RGS), which is ...
... scientists, engineers and physicians from Brigham and Women,s ... School (HMS), Massachusetts Institute of Technology (MIT), BIND ... University Karmanos Cancer Institute, and Weill Cornell Medical ... targeted cancer drug called BIND-014 in treating solid ...
... (HealthDay News) -- Really, really liking yourself may give ... new study suggests. That,s because narcissists, known to ... talk about and promote themselves, which projects confidence and ... In their two-part study, narcissists scored much higher in ...
... MA (April 4, 2012)-- IntegraGen, Inc., a biotechnology company ... of the ARISk Risk Assessment Test, a gender specific, ... associated with Autism Spectrum Disorder (ASD). The test is ... from multiplex familiessiblings of children with ASD who are ...
Cached Medicine News:Health News:More Fake Avastin Found in U.S., FDA Says 2Health News:Depo-Provera Birth Control Might Raise Breast Cancer Risk 2Health News:Antibody therapy prevents gastrointestinal damage following radiation exposure in mice 2Health News:First targeted nanomedicine to enter human clinical studies 2Health News:First targeted nanomedicine to enter human clinical studies 3Health News:First targeted nanomedicine to enter human clinical studies 4Health News:Narcissists Often Ace Job Interviews, Study Finds 2Health News:IntegraGen launches ARISk test, a genetic screening tool for autism in high-risk children 2Health News:IntegraGen launches ARISk test, a genetic screening tool for autism in high-risk children 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: